Catalyst
Slingshot members are tracking this event:
Topline results of PRX002 from Phase 1b multiple ascending dose study in patients with Parkinson's disease expected in the fourth quarter of 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PRTA | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 09, 2016
Occurred Source:
http://ir.prothena.com/releasedetail.cfm?ReleaseID=998603
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Prx002, Phase 1b, Parkinson's Disease, Q4 2016
